Abstract:Various stresses, including pressure overload and myocardial stretch, can trigger cardiac remodeling and result in heart diseases. The disorders are associated with high risk of morbidity and mortality and are among the major health problems in the world. MicroRNAs, a class of ~22nt-long small non-coding RNAs, have been found to participate in regulating heart development and function. One of them, miR-208a, a cardiac-specific microRNA, plays key role(s) in modulating gene expression in the heart, and is involved in a broad array of processes in cardiac pathogenesis. Genetic deletion or pharmacological inhibition of miR-208a in rodents attenuated stress-induced cardiac hypertrophy and remodeling. Transgenic expression of miR-208a in the heart was sufficient to cause hypertrophic growth of cardiomyocytes. miR-208a is also a key regulator of cardiac conduction system, either deletion or transgenic expression of miR-208a disturbed heart electrophysiology and could induce arrhythmias. In addition, miR-208a appeared to assist in regulating the expression of fast- and slow-twitch myofiber genes in the heart. Notably, this heart-specific miRNA could also modulate the “endocrine” function of cardiac muscle and govern the systemic energy homeostasis in the whole body. Despite of the critical roles, the underlying regulatory networks involving miR-208a are still elusive. Here, we summarize the progress made in understanding the function and mechanisms of this important miRNA in the heart, and propose several topics to be resolved as well as the hypothetical answers. We speculate that miR-208a may play diverse and even opposite roles by being involved in distinct molecular networks depending on the contexts. A deeper understanding of the precise mechanisms of its action under the conditions of cardiac homeostasis and diseases is needed. The clinical implications of miR-208a are also discussed.

MiR-466h-5p Induces Expression of Myocardin with Complementary Promoter Sequences

Cardiac Hypertrophy and Dysfunction Induced by Overexpression of Mir-214 in Vivo

The Mechanism of Myocardial Hypertrophy Regulated by the Interaction Between Mhrt and Myocardin.

LncRNA-Mhrt Regulates Cardiac Hypertrophy by Modulating the Mir-145A-5p/klf4/myocardin Axis.

Mir-9 and NFATc3 Regulate Myocardin in Cardiac Hypertrophy

Myocardin-Related Transcription Factor-A Induces Cardiomyocyte Hypertrophy

miR-10a regulates proliferation of human cardiomyocyte progenitor cells by targeting GATA6.

Expression of Micrornas is Dynamically Regulated During Cardiomyocyte Hypertrophy

miRNA-204 drives cardiomyocyte proliferation via targeting Jarid2

Microrna-340-5p Functions Downstream Of Cardiotrophin-1 To Regulate Cardiac Eccentric Hypertrophy And Heart Failure Via Target Gene Dystrophin

Down-regulation of miR-1/miR-133 Contributes to Re-expression of Pacemaker Channel Genes HCN2 and HCN4 in Hypertrophic Heart,

The Expression Of Microrna In Adult Rat Heart With Isoproterenol-Induced Cardiac Hypertrophy

Cardiac Hypertrophy Is Positively Regulated by MicroRNA miR-23a

The role of lncRNAKCNQ1OT1/miR-301b/Tcf7 axis in cardiac hypertrophy

MiR-27a-3p/Hoxa10 Axis Regulates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting Kv4.3 Expression

Microrna-497 Inhibits Cardiac Hypertrophy By Targeting Sirt4

An Intragenic Srf-Dependent Regulatory Motif Directs Cardiac-Specific Microrna-1-1/133a-2 Expression

NF-κB (p65) Negatively Regulates Myocardin-Induced Cardiomyocyte Hypertrophy Through Multiple Mechanisms

Myocardin Induces Cardiomyocyte Hypertrophy

Abstract 836: Downregulation of Microrna-1/Microrna-133 and Overexpression of Sp1 Activates Re-expression of Pacemaker Channel Genes HCN2 and HCN4 in Hypertrophic Heart

miR-208a in Cardiac Hypertrophy and Remodeling